Published in Hospital Business Week, July 22nd, 2007
Study 1: Researchers detail in "Aldosterone antagonism fails to attenuate age-associated left ventricular fibrosis," new data in hypertension. According to a study from the United States, "Collagen accumulates disproportionately in cardiac remodeling induced by hypertension and associated with advancing age. Spironolactone (Spiro), an aldosterone antagonist, attenuates the accumulation of collagen induced by hypertension."
"It was hypothesized that Spiro would attenuate the age-associated increase in percent collagen in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week